Peter J Stengel

age ~58

from Longmont, CO

Get Report

Also known as:

Peter John Stengel

Phone and address:: 1525 Cambridge Dr, Longmont, CO 80503
3037724639

Connected to:

Peter Stengel Phones & Addresses

1525 Cambridge Dr, Longmont, CO 80503 • 3037724639
4322 Castle Rock Ct, Irving, TX 75038 • 9727174028
Waukegan, IL
680 Lashley Ln, Boulder, CO 80303
1708 Cato Cir, Lafayette, CO 80026 • 3039268592
Evanston, IL
Ann Arbor, MI
Sandusky, OH
1525 Cambridge Dr, Longmont, CO 80503 • 3039070653

Work

Company:

Array biopharma
Position:

Associate director, process chemistry

Education

Degree:

Ph.D.
School / High School:

University of Michigan
Specialities:

Organic Chemistry

Emails

p***[email protected]

Industries

Pharmaceuticals

Medicine Doctors

Peter F. Stengel

view source

Specialties:

General Practice, Internal Medicine

Work:

Southern Prince Georges County Community Based Outpatient Clinic
5801 Allentown Rd, Suitland, MD 20746
3013452463 (phone), 3014238388 (fax)

Education:

Medical School
University of Buffalo, SUNY School of Medicine and Biomedical Sciences
Graduated: 1995

Procedures:

Cardiac Stress Test
Destruction of Benign/Premalignant Skin Lesions
Electrocardiogram (EKG or ECG)
Hearing Evaluation
Pulmonary Function Tests

Conditions:

Atrial Fibrillation and Atrial Flutter
Benign Prostatic Hypertrophy
Chronic Renal Disease
Constipation
Dementia

Languages:

English
Spanish

Description:

Dr. Stengel graduated from the University of Buffalo, SUNY School of Medicine and Biomedical Sciences in 1995. He works in Camp Springs, MD and specializes in General Practice and Internal Medicine.

Resumes

Peter Stengel

view source

Position:

Associate Director, Process Chemistry at Array BioPharma

Location:

Greater Denver Area

Industry:

Pharmaceuticals

Work:

Array BioPharma
Associate Director, Process Chemistry
Abbott Laboratories 1996 - 1999
Process Chemist

Education:

University of Michigan
Ph.D., Organic Chemistry University of Colorado at Boulder
Post-Doc, Organic Chemistry Capital University
Bachelors, Chemistry

Us Patents

Retroviral Protease Inhibiting Compounds
view source
US Patent:

6472529, Oct 29, 2002
Filed:

Apr 18, 2001
Appl. No.:

09/837280
Inventors:

Hing Leung Sham - Mundelein IL
Daniel W. Norbeck - Crystal Lake IL
Xiaoqi Chen - Libertyville IL
David A. Betebenner - Gurnee IL
Dale J. Kempf - Libertyville IL
Thomas R. Herrin - Waukegan IL
Gondi N. Kumar - Round Lake Beach IL
Stephen L. Condon - Kenosha WI
Arthur J. Cooper - Lake Villa IL
Daniel A. Dickman - Grayslake IL
Steven M. Hannick - Highland Park IL
Lawrence Kolaczkowski - Gurnee IL
Patricia A. Oliver - Lindenhurst IL
Daniel J. Plata - Waukegan IL
Peter J. Stengel - Waukegan IL
Eric J. Stoner - Kenosha WI
Jih-Hua Liu - Greek Oaks IL
Ketan M. Patel - Arlington Heights IL
Assignee:

Abbott Laboratories - Abbott Park IL
International Classification:

C07D23332
US Classification:

544316, 540488, 540492, 540531, 544 88, 544 97, 544332, 546220, 546243, 548229, 548233, 5483241, 5483315, 548550
Abstract:

A compound of the formula: is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.

Heterocyclic Antiviral Compounds
view source
US Patent:

7479489, Jan 20, 2009
Filed:

Aug 22, 2005
Appl. No.:

11/208962
Inventors:

James F. Blake - Longmont CO, US
Jay Bradford Fell - Longmont CO, US
John P. Fischer - Longmont CO, US
Robert Than Hendricks - San Carlos CA, US
John E. Robinson - Commerce City CO, US
Stacey Renee Spencer - Lyons CO, US
Peter J. Stengel - Longmont CO, US
Assignee:

Roche Palo Alto LLC - Palo Alto CA
International Classification:

C07D 417/02
A61K 31/5415
US Classification:

5142242, 544 52
Abstract:

Compounds having the formula I wherein A, m and Rare herein defined are Hepatitis C virus polymerase inhibitors. Also disclosed are compositions and methods for treating diseases mediated by HCV and for inhibiting hepatitis replication. Also disclosed are processes for making the compounds and synthetic intermediates used in the process.

Macrocyclic Compounds As Inhibitors Of Viral Replication
view source
US Patent:

7491794, Feb 17, 2009
Filed:

Mar 29, 2005
Appl. No.:

11/093884
Inventors:

Lawrence M. Blatt - San Francisco CA, US
Steven W. Andrews - Longmont CO, US
Kevin R. Condroski - Broomfield CO, US
Yutong Jiang - Longmont CO, US
April L. Kennedy - Denver CO, US
Peter J. Stengel - Longmont CO, US
Steven M. Wenglowsky - Boulder CO, US
Assignee:

Intermune, Inc. - Brisbane CA
International Classification:

A61K 38/12
US Classification:

530317
Abstract:

The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

Heterocyclic Antiviral Compounds
view source
US Patent:

7531534, May 12, 2009
Filed:

Feb 15, 2007
Appl. No.:

11/706777
Inventors:

Jay Bradford Fell - Longmont CO, US
Peter Mohr - Longmont CO, US
Peter J. Stengel - Longmont CO, US
Assignee:

Roche Palo Alto LLC - Palo Alto CA
International Classification:

C07D 417/02
A61K 31/5415
US Classification:

5142242, 544 52
Abstract:

Compounds having the formula Ia or Ib wherein R, R, Rand Rare as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.

1,1-Dioxo-1H-1Λ-Benzo[D]Isothiazol-3-Yl)-4-Hydroxy-1,5-Dihydro-Pyrrol-2-One Inhibitors Of Hcv Polymerase
view source
US Patent:

7674810, Mar 9, 2010
Filed:

Apr 28, 2006
Appl. No.:

11/413872
Inventors:

James F. Blake - Longmont CO, US
Jay Bradford Fell - Longmont CO, US
John P. Fischer - Longmont CO, US
Robert Than Hendricks - San Carlos CA, US
Stacey Renee Spencer - Lyons CO, US
Peter J. Stengel - Longmont CO, US
Assignee:

Roche Palo Alto LLC - Palo Alto CA
International Classification:

A01N 43/80
US Classification:

514373, 548206, 548207
Abstract:

Compounds having the formula i wherein m, R, R, Rand Xare herein defined are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for inhibiting hepatitis replication, processes for making the compounds and synthetic intermediates used in the process.

Retroviral Protease Inhibiting Compounds
view source
US Patent:

7968707, Jun 28, 2011
Filed:

Feb 27, 2007
Appl. No.:

11/679227
Inventors:

Hing Leung Sham - Mundelein IL, US
Daniel W. Norbeck - Crystal Lake IL, US
Xiaoqi Chen - Libertyville IL, US
David A. Betebenner - Gurnee IL, US
Dale J. Kempf - Libertyville IL, US
Thomas R. Herrin - Waukegan IL, US
Gondi N. Kumar - Round Lake Beach IL, US
Stephen L. Condon - Kenosha WI, US
Arthur J. Cooper - Lake Villa IL, US
Daniel A. Dickman - Grayslake IL, US
Steven M. Hannick - Highland Park IL, US
Lawrence Kolaczkowski - Gurnee IL, US
Patricia A. Oliver - Lindenhurst IL, US
Daniel J. Plata - Wads Worth IL, US
Peter J. Stengel - Waukegan IL, US
Eric J. Stoner - Kenosha WI, US
Jih-Hua Liu - Greek Oaks IL, US
Ketan M. Patel - Arlington Heights IL, US
Assignee:

Abbott Laboratories - Abbott Park IL
International Classification:

C07D 219/04
C07D 291/06
C07D 243/04
C07D 265/12
C07D 413/12
C07D 239/02
US Classification:

540488, 540492, 540460, 544 88, 544 97, 544316, 544332, 546233, 548229, 548233, 5483241, 5483315, 548550, 514218, 5142288, 514256, 514274, 514376, 514377, 514392, 51421203, 514331, 514428
Abstract:

A compound of the formula:.

Retroviral Protease Inhibiting Compounds
view source
US Patent:

20030100755, May 29, 2003
Filed:

Oct 25, 2002
Appl. No.:

10/280652
Inventors:

Hing Sham - Mundelein IL, US
Daniel Norbeck - Crystal Lake IL, US
Xiaoqi Chen - Libertyville IL, US
David Betebenner - Gurnee IL, US
Dale Kempf - Libertyville IL, US
Thomas Herrin - Waukegan IL, US
Gondi Kumar - Round Lake Beach IL, US
Stephen Condon - Kenosha WI, US
Arthur Cooper - Lake Villa IL, US
Daniel Dickman - Grayslake IL, US
Steven Hannick - Highland Park IL, US
Lawrence Kolaczkowski - Gurnee IL, US
Patricia Oliver - Lindenhurst IL, US
Daniel Plata - Wads Worth IL, US
Peter Stengel - Waukegan IL, US
Eric Stoner - Kenosha WI, US
Jih-Hua Liu - Greek Oaks IL, US
Ketan Patel - Arlington Heights IL, US
International Classification:

C07D279/06
C07D277/12
C07D277/34
US Classification:

544/053000, 544/088000, 544/311000, 544/316000, 548/182000, 548/229000, 548/316400, 548/317100
Abstract:

A compound of the formula: is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.

Akt Protein Kinase Inhibitors
view source
US Patent:

20050130954, Jun 16, 2005
Filed:

Nov 19, 2004
Appl. No.:

10/993173
Inventors:

Ian Mitchell - Lafayette CO, US
Keith Spencer - Lyons CO, US
Peter Stengel - Longmont CO, US
Yongxin Han - Longmont CO, US
Nicholas Kallan - Boulder CO, US
Mark Munson - Louisville CO, US
Guy Vigers - Boulder CO, US
James Blake - Longmont CO, US
Anthony Piscopio - Longmont CO, US
John Josey - Longmont CO, US
Scott Miller - Longmont CO, US
Dengming Xiao - Longmont CO, US
Riu Xu - Longmont CO, US
Chang Rao - Waltham MA, US
Bin Wang - Longmont CO, US
April Bernacki - Longmont CO, US
International Classification:

A61K031/53
A61K031/519
A61K031/496
US Classification:

514210210, 514264100, 514256000, 514249000, 514248000, 514266200, 514246000, 514314000, 514252160, 514253060, 544279000, 544182000, 544284000, 544363000, 546122000, 546117000, 514300000
Abstract:

The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: A-L-CR where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.